Company: OPGN
Filing Date: 2025-10-01
Form Type: 10-Q
Source: 0001829126-25-007819
Chunk: 64

Company: OPGEN INC
Filing Date: 2025-10-01
Form: 10-Q
Item: Part I, Item 8
Chunk 64
---
ive Plan

In April 2015, the Company adopted, and the Company’s stockholders approved, the 2015 Equity Incentive Plan (the “2015 Plan”); the 2015 Plan became effective upon the execution and delivery of the underwriting agreement for the Company’s initial public offering in May 2015. The 2015 Plan provides for the granting of incentive stock options within the meaning of Section 422 of the Code to employees and the granting of non-qualified stock options to employees, non-employee directors and consultants. The 2015 Plan also provides for the grant of restricted stock, restricted stock units, stock appreciation rights, dividend equivalents and stock payments to employees, non-employee directors and consultants. Effective April 1, 2025, which is the ten (10) year anniversary of the adoption of the 2015 Plan, no additional grants may be made under the 2015 Plan.

    19

Stock Options

For the three months ended March 31, 2025 and 2024, the Company recognized share-based compensation expense as follows:

    Schedule of company recognized stock compensation expense

    Three Months Ended March 31,

    2025

    2024

    Cost of services
     
    $
    -

    $
    -

    Research and development

    -

    25,856

    General and administrative

    81,708

    157,984

    Sales and marketing

    -

    4,397

    $
    81,708

    $
    188,237

No income tax benefit for share-based compensation arrangements was recognized in the unaudited condensed consolidated statements of operations and comprehensive income (loss) due to the Company’s anticipated net taxable loss position for the year ended December 31, 2025.

As of March 31, 2025, the Company does not have any unrecognized expense related to its stock options.

The Company did not grant any options during the three months ended March 31, 2025 or 2024. During the three months ended March 31, 2025, no options were forfeited or expired. During the three months ended March 31, 2024, 83 options were forfeited, and 88 options expired.

The Company had stock options to acquire 138 shares of common stock outstanding at March 31, 2025.

Restricted Stock Units

During
the three months ended March 31, 2025, no restricted